LSKL, Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide, inhibits thrombospondin (TSP-1) activation of TGF-β and prevents the progression of hepatic damage and fibrosis.
CAT No: R1490
CAS No:283609-79-0
Synonyms/Alias:283609-79-0;H-Leu-Ser-Lys-Leu-NH2;LSKL, Inhibitor of Thrombospondin (TSP-1);(2S)-6-amino-N-[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]hexanamide;H-Leu-Ser-Lys-Leu-NH2 trifluoroacetate salt;L-Leucyl-L-seryl-L-lysyl-L-leucinamide;LSKL-NH2;Leu-Ser-Lys-Leu peptide;leucyl-seryl-lysyl-leucyl peptide;LSKL;H-Leu-Ser-Lys-Leu-NH;TSP-1 inhibitor peptide LSKL;HY-P0299;Inhibitor of Thrombospondin ;TSP-1;AC-31401;DA-74214;FL109362;MS-28396;PD078448;Leu-Ser-Lys-Leu-NH2, >=95% (HPLC);G13182;LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA) LSKL;
Chemical Name:(2S)-6-amino-N-[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]hexanamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More